Disease evidence hub
A curated view of published Malaria research, auditable classifier relationships, and its publication timeline.
Evidence timeline
Monthly publication counts from the catalogue show how research activity changes over time.
24 publication months · peak 2026-10 (31)Guidance and policy markers identify dated publications in the curated catalogue; they do not by themselves establish that an official policy changed on that date.
Evidence stream
30 of 481 publications shown
The American Journal of Tropical Medicine and Hygiene
Why it matters now The findings are relevant to malaria elimination in the Philippines: the authors suggest that molecular monitoring of pfhrp2 deletions in routine surveillance could improve assessment of RDT performance and support elimination strategies targeting 2030.
Antimicrobial Agents and Chemotherapy
Why it matters now The results identify proteasome inhibitors as potential antimalarial drug candidates in the context of increasing drug resistance and support further investigation of their structure, dosing, and combination regimens. The evidence is preclinical and does not establish clinical efficacy or safety.
Antimicrobial Agents and Chemotherapy
Why it matters now If further clinical evaluation supports the modeled performance, the single-dose regimen could address barriers associated with multi-day treatment and potentially support less frequent seasonal chemoprevention cycles while maintaining impact.
The American Journal of Tropical Medicine and Hygiene
Why it matters now The abstract identifies malaria vaccine introduction as an opportunity to integrate vaccination with preventive health services intended to reduce childhood morbidity and mortality.
BMC Public Health
Why it matters now The authors suggest that context-specific housing and environmental measures could complement established malaria interventions, particularly in marginalized rural communities.
The American Journal of Tropical Medicine and Hygiene
Why it matters now The report supports consideration of follow-up for at least four weeks after artemether–lumefantrine because delayed hemolysis and recrudescence may occur.
Nature Communications
Why it matters now The findings are relevant to malaria transmission research because they connect a parasite regulatory protein with gamete fertility and mosquito infectivity. The supplied abstract does not evaluate human outcomes, prevention measures, treatments, or intervention effectiveness.
Environmental Research Letters
Why it matters now The projected expansion of vector habitat and population exposure may increase the geographic context in which malaria control is needed, supporting region-specific approaches that address population and environmental influences together.
Wellcome Open Research
Why it matters now The toolkit is presented as a foundation for genomic surveillance to inform vector control and malaria elimination in Southeast Asia, where vector diversity and insecticide resistance complicate control.
East African Journal of Arts and Social Sciences
Why it matters now The findings underscore contextual and interpretive influences on voluntary uptake of malaria control guidance, offering considerations for implementation scholarship.
Biosensors and Bioelectronics
Why it matters now Malaria disproportionately affects resource-limited tropical and subtropical regions where skilled microscopy operators may be scarce. A low-cost, automated diagnostic tool could reduce dependence on operator expertise and support more consistent parasitemia monitoring in such settings.
Malaria Journal
Why it matters now Authors conclude that targeted capacity building through blended methods is considered essential to improve service delivery and pursuit of elimination goals.
Frontiers in Public Health
Why it matters now Results suggest social media analytics could augment conventional malaria surveillance and community engagement, but should not replace dedicated elimination efforts.
Nature Communications
Why it matters now The authors propose that PfEBA175, PfRh2b and PfRh4 may form a critical nexus of the invasion machinery and that combinatorial targeting of these ligands could be a beneficial therapeutic approach. This is a proposed therapeutic implication, not evidence of clinical or surveillance impact.
HEALTH SCIENCES AND DISEASE
Why it matters now Silent infection among delivering women is present at the site, supporting calls to reinforce ITN and IPT use; more sensitive molecular methods are advised for future work.
Frontiers in Malaria
Why it matters now The compounds are presented as early hit candidates that may help diversify malaria treatment options amid drug-resistance challenges, pending further development.
G3: Genes, Genomes, Genetics
Why it matters now The assemblies offer a genomic resource for research on parasite evolution, transmission, and antigenic diversity in malaria-endemic settings.
International Journal of Global Health and Epidemiology
Why it matters now A considerable malaria burden exists among young children in Kogi State. Combined prevention and environmental-health actions plus larger local studies were suggested by the authors.
Pharmaceutics
Why it matters now The compound may support development of a treatment that also curbs malaria transmission, based on the reported dual activity.
Annual Review of Microbiology
Why it matters now Malaria imposes a large health burden, and mapping host-pathogen interactions supports development of improved preventive and therapeutic tools.
PLOS Neglected Tropical Diseases
Why it matters now The work addresses the need for improved P. vivax vaccines, since CSP-based approaches offer limited protection and dormant hypnozoites drive relapse and transmission; pre-erythrocytic antigens could prevent clinical malaria from primary and relapse infections.
BMC Infectious Diseases
Why it matters now The work highlights fragmented resistance evidence and the need for integrated molecular, phenotypic, and therapeutic monitoring to clarify clinical impact in the region.
Frontiers in Public Health
Why it matters now Results support geographically targeted, multisectoral action that joins malaria control with social, economic, and environmental measures for childhood anemia.
Nature Communications
Why it matters now High mortality from severe malaria in African children motivates adjunctive agents; this trial supports further study of sevuparin dosing.
PLOS Neglected Tropical Diseases
Why it matters now The work underscores the need for dependable disease reporting during emergencies and adaptable forecasting to aid vector-borne disease control in China.
Communicable Diseases Intelligence
Why it matters now Local risk persists due to high PNG incidence and treaty-related movement. Continued cross-border collaboration and stronger surveillance are needed to limit importation of malaria and other pathogens.
mSystems
Why it matters now Accounting for host cell heterogeneity may improve within-host growth predictions and refine timing of hemoglobin-dependent antimalarial use, with possible relevance to other intracellular infections.
Parasites, Hosts and Diseases
Why it matters now Salivary PfHRP2 appears weak for predicting infection metrics here, though more sensitive saliva assays might later aid diagnosis and treatment guidance.
Frontiers in Cellular and Infection Microbiology
Why it matters now The prioritized district map can support targeted surveillance and vector control during peak season to reduce re-establishment risk from imported parasites.
PLOS Neglected Tropical Diseases
Why it matters now The assay may serve as a sensitive complementary option for malaria surveillance in low-transmission and elimination contexts, especially where low-density infections evade microscopy.
